Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

GSK’s revenue drops by 18% in Q1 as performance pressures mount

Chief executive Emma Walmsley said results ‘reflect the anticipated impacts of COVID-19’

- PMLiVE

Novartis announces delay in UK cholesterol drug study

The delay was caused by recruitment issues during the COVID-19 pandemic

- PMLiVE

ICR appoints Kristian Helin as its new chief executive

Helin will join ICR in September from the Memorial Sloan Kettering Cancer Center in the US

- PMLiVE

Lilly cuts 2021 guidance to reflect ‘lower expected revenue’ from COVID-19 antibody sales

FDA recently removed emergency authorisation for bamlanivimab monotherapy

- PMLiVE

Pfizer CEO says oral COVID-19 pill could be ready by the end of the year

Company initiated a phase 1 study of the drug last month

- PMLiVE

FDA panel votes to keep accelerated approval for Roche’s Tecentriq in breast cancer

Oncologic Drugs Advisory Committee voted seven to two in favour of drug

- PMLiVE

Pharma marketers’ blog: How to be a patient-centric pharma marketer?

Understanding that patients are a person first and a patient second

- PMLiVE

A personal perspective on autism

The whole month of April is Autism Awareness Month. To help mark the end of such an important month we’re sharing a personal perspective to spread kindness and autism awareness:When...

Lucid Group Communications Limited

- PMLiVE

PulmoBioMed Wins National Life Science Competition

Newly launched Northumbria University spinout PulmoBioMed has been handpicked as the winners of Onyx Health's ThinkBig competition

Onyx Health

Biogen Idec building

Biogen to open compassionate use programme for ALS patients with ‘rapidly progressive disease’

Move comes after mounting pressure from patients and campaigners

- PMLiVE

AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial

Drug reduced lower respiratory tract infections caused by respiratory syncytial virus in infants

- PMLiVE

FDA removes clinical hold on uniQure’s haemophilia gene therapy

Clinical hold placed following a case of hepatocellular carcinoma in a patient in the trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links